Topic 13: Neuromuscular Junction Disorders

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/56

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

57 Terms

1
New cards

What is the neuromuscular junction (NMJ)?

A specialized synapse where the terminal end of a lower motor neuron (LMN) meets the muscle fiber membrane.

2
New cards

What is found in the presynaptic terminal of the NMJ?

Synaptic vesicles filled with acetylcholine (ACh).

3
New cards

What is the synaptic cleft?

The gap between the nerve terminal and the muscle membrane.

4
New cards

What is found in the postsynaptic membrane of the NMJ?

Acetylcholine receptors (AChRs) concentrated in junctional folds.

5
New cards

What happens when an action potential reaches the NMJ?

It opens voltage-gated calcium channels in the nerve terminal.

6
New cards

What does calcium influx cause at the NMJ?

Fusion of synaptic vesicles with the membrane and release of ACh.

7
New cards

What happens after ACh is released?

It diffuses across the synaptic cleft and binds to AChRs on the muscle membrane.

8
New cards

How does binding of ACh to its receptor cause contraction?

It changes muscle membrane permeability, triggering an action potential in the muscle fiber.

9
New cards

What stops the NMJ signal?

Acetylcholinesterase breaks down acetylcholine, ending stimulation and allowing relaxation.

10
New cards

What are the two main categories of NMJ pathophysiology?

1) Defective release of ACh (pre-junctional pathology)

2) Destruction/blockade of ACh receptors (post-junctional pathology).

11
New cards

What is the hallmark symptom of NMJ disorders?

Muscle weakness.

12
New cards

Do NMJ disorders cause sensory loss?

No, sensation is spared.

13
New cards

What causes botulism?

The neurotoxin from Clostridium botulinum.

14
New cards

What is the mechanism of botulism at the NMJ?

The toxin blocks calcium-mediated exocytosis of synaptic vesicles, preventing ACh release.

15
New cards

What are the clinical features of botulism?

Flaccid paralysis, descending symmetrical weakness, cranial nerve involvement, and possible respiratory muscle paralysis.

16
New cards

What is Lambert-Eaton Myasthenic Syndrome (LEMS)?

A paraneoplastic syndrome, often associated with small cell lung carcinoma.

17
New cards

What is the mechanism of LEMS at the NMJ?

Autoantibodies attack presynaptic voltage-gated calcium channels, reducing ACh release.

18
New cards

What are the clinical features of LEMS?

Proximal muscle weakness, autonomic symptoms (e.g., dry mouth, impotence), and strength that often improves with activity.

19
New cards

What is Myasthenia Gravis (MG)?

An autoimmune disease in which antibodies attack acetylcholine receptors (AChRs) on the muscle membrane.

20
New cards

What is the mechanism of MG at the NMJ?

Destruction of AChRs reduces the number of functional receptors, impairing neuromuscular transmission.

21
New cards

What are the hallmark clinical features of MG?

Fluctuating weakness, especially ptosis (drooping eyelid) and diplopia (double vision), bulbar symptoms (speech, swallowing), fatigability that worsens with use and improves with rest.

22
New cards

How is Myasthenia Gravis diagnosed?

Elevated AChR antibodies, fatigability on repetitive stimulation, and improvement with anticholinesterase drug (Tensilon test).

23
New cards

What is the mechanism of Lambert-Eaton Myasthenic Syndrome (LEMS)?

Autoantibodies block presynaptic voltage-gated calcium channels → decreased ACh release.

24
New cards

What are the clinical features of LEMS?

Proximal muscle weakness (often legs more than arms), autonomic symptoms (dry mouth, impotence), often paraneoplastic.

25
New cards

How does LEMS differ clinically from MG?

LEMS strength may improve transiently with exertion ("facilitation"), while MG worsens with use.

26
New cards

What is the mechanism of botulism?

Toxin from Clostridium botulinum prevents presynaptic release of acetylcholine.

27
New cards

What are the clinical features of botulism?

Acute, descending, symmetric paralysis starting with cranial nerve palsies; may cause respiratory failure.

28
New cards

What is the hallmark of all neuromuscular junction (NMJ) disorders?

Muscle weakness without sensory loss.

29
New cards

In Myasthenia Gravis, which muscles are often affected early?

Extraocular (causing diplopia) and eyelid elevators (causing ptosis); also bulbar muscles.

30
New cards

How does fatigability present in Myasthenia Gravis?

Weakness worsens with exertion and improves with rest.

31
New cards

How does facilitation present in Lambert-Eaton syndrome?

Muscle strength may improve temporarily after exertion.

32
New cards

Which NMJ disorders affect ACh release?

Botulism and LEMS.

33
New cards

Which NMJ disorder affects ACh receptors?

Myasthenia Gravis.

34
New cards

What serologic tests help confirm NMJ disorders?

ACh receptor antibody titers (MG) and anti-VGCC antibodies (LEMS).

35
New cards

What electrophysiologic test helps diagnose NMJ disorders?

Repetitive nerve stimulation: decremental response in MG; incremental response in LEMS.

36
New cards

What pharmacologic test can help diagnose Myasthenia Gravis?

Edrophonium (Tensilon) test → temporary improvement in strength.

37
New cards

What is another bedside test that can help in MG with ptosis/diplopia?

Ice pack test → reduces ptosis, especially if diplopia also present.

38
New cards

What is the pathophysiology of Myasthenia Gravis (MG)?

Autoimmune attack against acetylcholine receptors (AChRs) at the neuromuscular junction, impairing synaptic transmission.

39
New cards

What is the hallmark symptom of MG?

Fluctuating muscle weakness that worsens with exertion and improves with rest.

40
New cards

Which muscles are most commonly affected first in MG?

Ocular muscles → ptosis and diplopia.

41
New cards

What percentage of MG patients present initially with ocular symptoms?

40-70% present with ocular symptoms initially; 85-90% develop them as disease progresses.

42
New cards

Which bulbar symptoms may occur in MG?

Dysarthria, dysphagia, chewing fatigue.

43
New cards

What is spared in MG, distinguishing it from neuropathies?

Sensation → MG is purely a motor disorder.

44
New cards

What test confirms MG by detecting autoantibodies?

Acetylcholine receptor antibody testing (positive in ~85% of generalized MG cases).

45
New cards

What electrophysiological test is used in MG, and what is an abnormal finding?

Repetitive nerve stimulation → >10% decrement in CMAP amplitude.

46
New cards

What is the Tensilon (Edrophonium) test, and what constitutes a positive result?

IV injection of short-acting acetylcholinesterase inhibitor; positive if there is temporary rapid improvement in muscle strength (e.g., ptosis).

47
New cards

What bedside test can help confirm MG in cases of ptosis/diplopia?

Ice pack test → improvement in ptosis after cooling the eyelid.

48
New cards

Why does the ice pack test work for MG?

Cold inhibits acetylcholinesterase, prolonging ACh action at the NMJ.

49
New cards

Why should all patients with MG be screened for thymoma?

~10-15% of MG patients have a thymoma; thymus plays a central role in MG pathogenesis.

50
New cards

What imaging is recommended in MG to rule out thymoma?

Chest imaging.

51
New cards

What is the first-line pharmacologic treatment for Myasthenia Gravis (MG)?

Acetylcholinesterase inhibitors (e.g., pyridostigmine), which enhance neuromuscular transmission by preventing ACh breakdown.

52
New cards

When is thymectomy indicated in MG?

In patients with thymoma, and often in younger patients with generalized MG, as it can improve symptoms or induce remission.

53
New cards

What role do corticosteroids and immunosuppressants play in MG treatment?

They are used when acetylcholinesterase inhibitors alone are insufficient; examples include prednisone, azathioprine, and mycophenolate.

54
New cards

What advanced therapies are used in severe or crisis cases of MG?

Plasmapheresis (removes circulating antibodies) and IVIG (provides passive immunity).

55
New cards

What is a myasthenic crisis, and how is it managed?

Life-threatening respiratory weakness due to severe MG exacerbation; managed with plasmapheresis, IVIG, and supportive ventilation if needed.

56
New cards

What percentage of MG patients have an associated thymoma?

Approximately 10-15%.

57
New cards

How is chiropractic care positioned in the management of MG?

Subluxation-based supportive care as an adjunct to medical management; described in case reports, not a replacement for medical therapy.